https://www.selleckchem.com/pr....oducts/tertiapin-q.h
01], 3-year (OR 0.33, 95% CI 0.22-0.51, P0.01) and 5-year overall survival (OS) rates (OR 0.31, 95% CI 0.20-0.49, P0.01) of the BDTT group were significantly worse than those of the non-BDTT group. The hazard ratio of HCC with BDTT was 4.27 (95% CI 3.47-5.26, P0.01) within 5 years after hepatectomy. HCC patients with BDTT had worse OS compared to patients free of BDTT after surgery. BDTT may be a potential prognostic factor for HCC patients. HCC patients with BDTT had worse OS compared to patients free of BDTT after surg
Like
Comment
Share
